FDA ELECTROSURGICAL DEVICE GUIDANCE INCLUDES REVISIONS OF INTENDED USE, EtO, WARNINGS PROVISIONS; CLINICAL SECTION NEEDS CLARIFICATION, INDUSTRY REP SAYS
This article was originally published in The Gray Sheet
FDA needs to provide additional guidance on when clinical data should be included in 510(k)s for electrosurgical devices, Robert O'Holla, the industry representative to the agency's General and Plastic Surgery Devices Panel, said at a Sept. 21 meeting of the advisory committee in Gaithersburg, Maryland.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.